Monthly Archives: July 2012

PERNIX THERAPEUTICS ANNOUNCES OMECLAMOX-PAK® NOW AVAILABLE IN PHARMACIES NATIONWIDE

PERNIX THERAPEUTICS ANNOUNCES OMECLAMOX-PAK® NOW AVAILABLE IN PHARMACIES NATIONWIDE Posted on 07/10/2012 Omeclamox-Pak Eradicates Helicobacter Pylori in Just Ten Days THE WOODLANDS, Texas, July 10, 2012—Pernix Therapeutics (NYSE: MKT: PTX), a specialty pharmaceutical company, today announced that Omeclamox-Pak® is now available to patients for the treatment of Helicobacter pylori (H....
Read more

Pernix Therapeutics Announces Agreement to Acquire Great Southern Laboratories

Enhances the Company’s Capabilities to Develop and Market Branded, Generic and OTC Products THE WOODLANDS, TEXAS, July 2, 2012 – Pernix Therapeutics Holdings, Inc. (“Pernix” or the “Company”) (NYSE MKT: PTX), a specialty pharmaceutical company, today announced that it has entered into a definitive agreement to acquire Great Southern Laboratories,...
Read more